Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

Breaking News

Congress returns to battles over DHS, expelling lawmakers and the Iran war

DHS Funding, Lawmaker Expulsions, Iran Conflict: Congress Reconvenes

Congress returns to a crowded agenda defined by frozen homeland security funding, competing immigration proposals, ethics probes involving several lawmakers, and a renewed discussion about the U.S. mi...

International

How peace processes balance stability and accountability

Peace Processes and the Stability-Accountability Nexus

How climate compliance is monitored when data is weak

Climate Compliance Monitoring: Navigating Weak Data

Insufficient or patchy environmental information poses a widespread obstacle for governments, regula...
Israel’s new spymaster is a Netanyahu aide who believed war with Iran would topple the regime

The New Head of Israeli Intelligence: Netanyahu Aide & Iran War Advocate

A major shift in Israel’s intelligence leadership is taking shape as tensions with Iran persist, and...

Economy

Warsaw, in Poland: How startups expand across Central Europe efficiently

Warsaw, in Poland: How startups expand across Central Europe efficiently

Warsaw has become one of Central Europe’s primary hubs for technology startups aiming to scale across the region. Its combination of deep technical talent, competitive operating co...

Investments and Business

How do investors assess regulatory risk in biotech and pharmaceuticals?

Regulatory Risk in Biotech & Pharma: An Investor’s View

Regulatory risk is one of the most critical variables investors evaluate when allocating capital to biotechnology and pharmaceutical companies. These industries are uniquely dependent on government agencies for product approval, labeling, manufacturing standards, and post-market ...